Skip to content
zameds

Oseltamivir (Flumitev)

Oseltamivir

Teva Pharmaceuticals (Pty) Ltd

S4Read from the PI-PIL document and verified

Registration

Applicant
Teva Pharmaceuticals (Pty) Ltd
Certificate holder
Teva Pharmaceuticals (Pty) Ltd
Registrations
3
Schedule source
SAHPRA documentation

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Flumitev 30

EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 30,0 mg

30Capsule56103556/20.2.8/1035Approved 10 September 2024RegisteredS4PIPIL
Flumitev 45

EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg

45Capsule56103656/20.2.8/1036Approved 10 September 2024RegisteredS4PIPIL
Flumitev 75

EACH CAPSULE CONTAINS OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg

75Capsule56103756/20.2.8/1037Approved 10 September 2024RegisteredS4PIPIL

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Oseltamivir phosphate equivalent to oseltamivir

  • S4: Oseltamivir

    Consolidated Schedules 06 July 2026, line 7416

Pharmacological class: Antiviral agents. (class 20.2.8)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C16H28N2O4312.40 g/mol

Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate

Drag to rotate. Structure from PubChem CID 65028.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

This medication's schedule (S4) has been verified from official SAHPRA documents with 90% confidence.

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles